XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]          
Intangible Assets, Gross (Excluding Goodwill) $ 5,627.0   $ 5,627.0   $ 5,423.6
Goodwill 8,217.6   8,217.6   7,958.9
Amortization of intangibles and other assets 65.2 $ 92.2 198.7 $ 276.7  
Adjustments to goodwill     (312.6)    
Estimated amortization expense, 2012 58.6   58.6    
Estimated amortization expense, 2013 264.4   264.4    
Estimated amortization expense, 2014 258.9   258.9    
Estimated amortization expense, 2015 244.2   244.2    
Estimated amortization expense, 2016 234.5   234.5    
Estimated amortization expense, Thereafter 2,194.2   2,194.2    
Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings     4.0    
Amortization of intangible assets 65.2 $ 92.2 198.7 $ 276.7  
LabCorp Diagnostics [Member]          
Finite-Lived Intangible Assets [Line Items]          
Goodwill 4,429.5   4,429.5   4,046.2
Adjustments to goodwill     (70.2)    
Covance Drug Development [Member]          
Finite-Lived Intangible Assets [Line Items]          
Goodwill $ 3,788.1   3,788.1   $ 3,912.7
Adjustments to goodwill     $ (242.4)